Results 111 to 120 of about 85,054 (209)

Characterizing the Fate of Anti-CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma. [PDF]

J Extracell Vesicles
De Coster M, Hyka L, De Cock S, Meeussen S, Wang Z, Tu C, Hernot S, Devoogdt N, David G, De Veirman K, Vanderkerken K, Menu E, Zimmermann P, De Bruyne E.   +13 more
europepmc   +1 more source

In Vivo Fate of Diatom-Based Nanocarriers: Advances, Challenges, and Future Perspectives. [PDF]

Int J Mol Sci
Naik K, De Stefano L, Rea I.
europepmc   +1 more source

Development of an Optimized CXCR4-Targeting Theranostic Pair. [PDF]

J Nucl Med
Kwon D, Bloise I, Zhang Z, Colpo N, Wilson R, Tan R, Merkens H, Zeisler J, Lau J, Lin KS, Bénard F.   +10 more
europepmc   +1 more source

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration. [PDF]

Chem Sci
Schuderer F, Silva RDM, Pinto CIG, Koller L, Stangl S, Gano L, Cavaco M, Castanho MAR, Mendes F, Kossatz S, Correia JDG, Casini A.   +11 more
europepmc   +1 more source

NIS-Centered Reporter Gene Imaging and Radionuclide-Integrated Nanoplatforms for Quantitative Tracking of Immune Cell Therapy in Oncology and Inflammatory Disease Models. [PDF]

Pharmaceuticals (Basel)
Lee SB.
europepmc   +1 more source

Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics. [PDF]

Sovrem Tekhnologii Med
Avrov KO, Shatik SV, Shashkova OA, Pinevich AA, Terekhina LA, Gryazeva IV, Zaitsev VV, Berlina MA, Stanzhevsky AA, Samoylovich MP.   +9 more
europepmc   +1 more source

Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeys. [PDF]

Mol Ther Adv
Vono M, Rio TD, Magdaleno E, Loll NR, Jarvis P, Walter C, Kikkawa R, Mansfield K, McBlane F, Sirivelu MP, Ozsolak F, Brees D, Hudry E, Rubic-Schneider T, Tukov FF, Huang G.   +15 more
europepmc   +1 more source

Establishment of ⁶⁸Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. [PDF]

Mol Pharm
Veach DR, Burnes Vargas D, Islam B, Lee SG, Gajecki L, Vaughn BA, Yang G, Kalidindi TM, Pillarsetty NVK, Salehi N, Jaswal AP, Saha S, Le Roux AB, Xu H, Guo HF, Ouerfelli O, Cheung NV, Krebs S, Larson SM, Cheal SM.   +19 more
europepmc   +1 more source

First-In-Human Evaluation of [18F]Fluproxadine for Norepinephrine Transporter PET: Biodistribution, Dosimetry, and Safety. [PDF]

Clin Nucl Med
Yamane T, Iimori H, Akamatsu G, Ikari Y, Hoda Y, Shimizu K, Matsumoto K, Senda M, Werner RA, Nose N, Chen X, Higuchi T.   +11 more
europepmc   +1 more source

Single-Domain Antibody Probe with Low Renal Uptake for Claudin 18.2-Targeted PET Imaging of Gastric Cancer: Preclinical and Pilot Clinical Evaluations. [PDF]

J Nucl Med
Zheng M, Ma H, Xu T, Mu H, Liu Q, Zhang K, Bian Y, Zhang H, Li W, Zhang B, Shan Y, Peng X, Qin S, Wang Y, Miao L.   +14 more
europepmc   +1 more source